Harry Janssen
MD, PhD
Erasmus MC, University Hospital Rotterdam, the Netherlands / Toronto Centre for Liver Disease, Canada
International Workshop on HBV Cure 2024
Thank you!
We are pleased to reflect on the highly successful workshop for the International Workshop on HBV Cure 2024, which took place as an in-person workshop on 13 November in San Diego, US - just before the AASLD liver meeting.
The Program Chair and organizers would like to thank the speakers, chairs, and all participants for their contribution to this meeting!
Special thanks to the all the workshop support. Without their contribution, this workshop would not have been made possible.
The International Workshop on HBV Cure 2024 was fully compliant by EthicalMedTech, underscoring our commitment to maintaining the highest ethical standards.
About This Program
Since 2014, the International Workshop on HBV Cure has been a scientific platform acting as a catalyst to accelerate the progress for achieving a cure. Around the globe, more than 250 million people live with hepatitis B (HBV). The purpose of the workshop is to inform the participants about the developments in the work to find a cure for HBV. The meeting will be highly interactive with input from experts out of the arena of basic, translational, and clinical HBV research.
The field of HBV treatment is undergoing major changes and is on the verge of a paradigm shift. The many new treatment options that are becoming available provide great hopes for decreasing the burden of the disease, simplifying treatment, and potentially curing and eradicating HBV infection.
In order to optimize curative treatment for HBV, outstanding speakers from around the globe will share the newest therapeutic options for viral hepatitis, and experts will discuss the path forward to cure this deadly disease, leading to liver cirrhosis and liver cancer. Questions on which endpoints to use in therapeutic trials and how to combine different agents targeting the virus and/or immune system will be extensively discussed.
This workshop also brings together global inter-disciplinary experts to provide a framework for how academia and industry should collaborate to achieve the goal of curing hepatitis B.
Program Directors
Adam Gehring
PhD
Toronto Centre for Liver Disease, Canada